Cargando…

Low High-Density Lipoprotein and Risk of Myocardial Infarction

Low HDL is an independent risk factor for myocardial infarction. This paper reviews our current understanding of HDL, HDL structure and function, HDL subclasses, the relationship of low HDL with myocardial infarction, HDL targeted therapy, and clinical trials and studies. Furthermore potential new a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, A., Hu, P. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670046/
https://www.ncbi.nlm.nih.gov/pubmed/26692765
http://dx.doi.org/10.4137/CMC.S26624
_version_ 1782404204261801984
author Ramirez, A.
Hu, P. P.
author_facet Ramirez, A.
Hu, P. P.
author_sort Ramirez, A.
collection PubMed
description Low HDL is an independent risk factor for myocardial infarction. This paper reviews our current understanding of HDL, HDL structure and function, HDL subclasses, the relationship of low HDL with myocardial infarction, HDL targeted therapy, and clinical trials and studies. Furthermore potential new agents, such as alirocumab (praluent) and evolocumab (repatha) are discussed.
format Online
Article
Text
id pubmed-4670046
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-46700462015-12-11 Low High-Density Lipoprotein and Risk of Myocardial Infarction Ramirez, A. Hu, P. P. Clin Med Insights Cardiol Short Review Low HDL is an independent risk factor for myocardial infarction. This paper reviews our current understanding of HDL, HDL structure and function, HDL subclasses, the relationship of low HDL with myocardial infarction, HDL targeted therapy, and clinical trials and studies. Furthermore potential new agents, such as alirocumab (praluent) and evolocumab (repatha) are discussed. Libertas Academica 2015-12-03 /pmc/articles/PMC4670046/ /pubmed/26692765 http://dx.doi.org/10.4137/CMC.S26624 Text en © 2015 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Short Review
Ramirez, A.
Hu, P. P.
Low High-Density Lipoprotein and Risk of Myocardial Infarction
title Low High-Density Lipoprotein and Risk of Myocardial Infarction
title_full Low High-Density Lipoprotein and Risk of Myocardial Infarction
title_fullStr Low High-Density Lipoprotein and Risk of Myocardial Infarction
title_full_unstemmed Low High-Density Lipoprotein and Risk of Myocardial Infarction
title_short Low High-Density Lipoprotein and Risk of Myocardial Infarction
title_sort low high-density lipoprotein and risk of myocardial infarction
topic Short Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670046/
https://www.ncbi.nlm.nih.gov/pubmed/26692765
http://dx.doi.org/10.4137/CMC.S26624
work_keys_str_mv AT ramireza lowhighdensitylipoproteinandriskofmyocardialinfarction
AT hupp lowhighdensitylipoproteinandriskofmyocardialinfarction